Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin L Masters

Showing results (681-690 of 776) with videos related to

Pageof 78
Sort By:
Arxiv|February 7, 2023
Gene-SGAN: a method for discovering disease subtypes with imaging and genetic signatures via multi-view weakly-supervised deep clusteringZhijian Yang, Junhao Wen, Ahmed Abdulkadir, et al.
International Journal of Molecular Sciences|April 3, 2021
Plasma Amyloid-Beta Levels in a Pre-Symptomatic Dutch-Type Hereditary Cerebral Amyloid Angiopathy Pedigree: A Cross-Sectional and Longitudinal InvestigationPratishtha Chatterjee, Michelle Tegg, Steve Pedrini, et al.
Science Bulletin|November 9, 2025
Performance of blood biomarkers in internal jugular vein for Alzheimer's disease pathologies: the Delta Method studyJun Wang, Dong-Yu Fan, Shan Huang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 16, 2013
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's diseaseAlan Rembach, Noel G Faux, Andrew D Watt, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 28, 2018
Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohortsRachel F Buckley, Elizabeth C Mormino, Rebecca E Amariglio, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) studyQiao-Xin Li, Victor L Villemagne, James D Doecke, et al.
Archives of Neurology|July 18, 2012
Blood-based protein biomarkers for diagnosis of Alzheimer diseaseJames D Doecke, Simon M Laws, Noel G Faux, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 6, 2024
Plasma and CSF neurofilament light chain distinguish neurodegenerative from primary psychiatric conditions in a clinical settingDhamidhu Eratne, Matthew J Y Kang, Courtney Lewis, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 29, 2022
Clinical impact of whole-genome sequencing in patients with early-onset dementiaAamira J Huq, Bryony Thompson, Mark F Bennett, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 6, 2012
Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's diseaseVictor L Villemagne, William E Klunk, Chester A Mathis, et al.
Pageof 78

Showing results (681-690 of 776) with videos related to

Sort By:
Pageof 78
Arxiv|February 7, 2023
Gene-SGAN: a method for discovering disease subtypes with imaging and genetic signatures via multi-view weakly-supervised deep clusteringZhijian Yang, Junhao Wen, Ahmed Abdulkadir, et al.
International Journal of Molecular Sciences|April 3, 2021
Plasma Amyloid-Beta Levels in a Pre-Symptomatic Dutch-Type Hereditary Cerebral Amyloid Angiopathy Pedigree: A Cross-Sectional and Longitudinal InvestigationPratishtha Chatterjee, Michelle Tegg, Steve Pedrini, et al.
Science Bulletin|November 9, 2025
Performance of blood biomarkers in internal jugular vein for Alzheimer's disease pathologies: the Delta Method studyJun Wang, Dong-Yu Fan, Shan Huang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 16, 2013
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's diseaseAlan Rembach, Noel G Faux, Andrew D Watt, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 28, 2018
Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohortsRachel F Buckley, Elizabeth C Mormino, Rebecca E Amariglio, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) studyQiao-Xin Li, Victor L Villemagne, James D Doecke, et al.
Archives of Neurology|July 18, 2012
Blood-based protein biomarkers for diagnosis of Alzheimer diseaseJames D Doecke, Simon M Laws, Noel G Faux, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 6, 2024
Plasma and CSF neurofilament light chain distinguish neurodegenerative from primary psychiatric conditions in a clinical settingDhamidhu Eratne, Matthew J Y Kang, Courtney Lewis, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 29, 2022
Clinical impact of whole-genome sequencing in patients with early-onset dementiaAamira J Huq, Bryony Thompson, Mark F Bennett, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 6, 2012
Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's diseaseVictor L Villemagne, William E Klunk, Chester A Mathis, et al.
Pageof 78